NCT02241928撤回1 期
Role of Autologous Mononuclear Cell Therapy in Muscular Dystrophy
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Manual Muscle Testing
研究概览
简要总结
The purpose of this study was to analyze the effect of autologous bone marrow mononuclear cells in muscular dystrophy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 6 Months 至 60 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age group of 6 months and above
- •muscular dystrophy diagnosed on the basis of clinical presentation
排除标准
- •presence of respiratory distress
- •presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus
- •malignancies
- •acute medical conditions such as respiratory infection, fever, hemoglobin less than 8, bleeding tendency, bone marrow disorder, left ventricular ejection fraction < 30%
- •pregnancy or breastfeeding
研究组 & 干预措施
Stem Cell
Experimental
Bone marrow mononuclear cell transplantation
干预措施: Stem Cell (Biological)
结局指标
主要结局
Manual Muscle Testing
时间窗: 1 year
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
撤回
1 期
Cell Therapy as Treatment for Cerebral PalsyCerebral PalsyNCT02241395Neurogen Brain and Spine Institute
撤回
1 期
Stem Cell Therapy in Incurable Neurological DisordersDisorder, Nervous System NeurologicalNCT02245776Neurogen Brain and Spine Institute
Unknown
不适用
Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI)Left Ventricular Function Systolic DysfunctionLeft Ventricular Function Diastolic DysfunctionMyocardial Reperfusion InjuryDeathNCT01307371Xijing Hospital110
已完成
1 期
Outcomes of Autologous Bone Marrow Mononuclear Cell Administration in the Treatment of Neurologic Sequelea in Children With Spina BifidaStem Cell InfusionNCT05472428Vinmec Research Institute of Stem Cell and Gene Technology11
已完成
2 期
Autologous BMMNCs Combined With Educational Intervention for ASDAutism Spectrum DisorderNCT05307536Vinmec Research Institute of Stem Cell and Gene Technology54